Tareq Abadl/LinkedIn
May 29, 2026, 13:49
Tareq Abadl: The Rh Blood Group System – Meet the 5 Antigens That Matter Most
Tareq Abadl, Medical Lab Specialist, shared a post on LinkedIn:
“The Rh Blood Group System – Meet the 5 Antigens That Matter Most
You know Rh+ and Rh−.
The Rh system has over 50 antigens — but D, C, c, E, and e are the 5 that account for most clinically significant transfusion complications.
D Antigen
- Frequency: ~85% of population
- Antibody: Anti-D (IgG)
- Most immunogenic Rh antigen
- Causes: severe HTR and HDFN
- Defines Rh+ vs Rh−
C Antigen
- Frequency: ~70%
- Antibody: Anti-C (IgG)
- Causes: mild-moderate HTR and HDFN
c Antigen
- Frequency: ~80%
- Antibody: Anti-c (IgG)
- Causes: HTR and HDFN
- Second most clinically significant after anti-D
E Antigen
- Frequency: ~30%
- Antibody: Anti-E (IgG)
- Causes: HTR and HDFN
e Antigen
- Frequency: ~98% — most common Rh antigen!
- Antibody: Anti-e (IgG) — rare but significant
- Causes: HTR and HDFN
Immunogenicity Order — Strongest to Weakest: D, E, C, c, and e
Key Rule:
All Rh antibodies are IgG, react best at 37°C, and should be considered potential causes of hemolytic transfusion reactions and HDFN.”
Other posts featuring Tareq Abadl on Hemostasis Today.
-
Oct 19, 2026, 16:04Hussnain Javaid: New EHA Guidelines for HbSC Disease Management
-
Oct 19, 2026, 15:50Deep Madkaiker: A New Academic Opportunity in Transfusion Medicine at ACTREC
-
Oct 19, 2026, 15:19Why Hematologists Should Care About Diminished Ovarian Reserve in SCD – ASH Education
-
Oct 19, 2026, 14:16Hyperfibrinolysis as an Underrecognized Cause of Bleeding
-
Oct 19, 2026, 13:36Shobhna Ladva: Aspen Pharma EME Raises Awareness of Blood Clot Risks During Hormonal Transitions
-
Oct 19, 2026, 13:11Giulia Furnari: Connecting With Global Hematology Experts at IACH 2026
-
Oct 19, 2026, 12:46Andrew Choong: Recognizing Thrombosis Before It Becomes Life-Threatening
-
Oct 19, 2026, 11:37Beth Faiman: APSHO Fellows Celebrated for Advancing Hematology and Oncology Practice
-
Oct 19, 2026, 11:26Emanuele Pacini: Myelodysplastic Syndromes Research Featured at JSH Annual Meeting in Kyoto